183 related articles for article (PubMed ID: 15979061)
1. Serum non-transferrin bound iron in hemodialysis patients not receiving intravenous iron.
Prakash M; Upadhya S; Prabhu R
Clin Chim Acta; 2005 Oct; 360(1-2):194-8. PubMed ID: 15979061
[TBL] [Abstract][Full Text] [Related]
2. Protein thiol oxidation and lipid peroxidation in patients with uraemia.
Prakash M; Upadhya S; Prabhu R
Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466
[TBL] [Abstract][Full Text] [Related]
3. Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose.
Pai AB; Conner T; McQuade CR; Olp J; Hicks P
Biometals; 2011 Aug; 24(4):603-13. PubMed ID: 21229380
[TBL] [Abstract][Full Text] [Related]
4. Effects of intravenous polymaltose iron on oxidant stress and non-transferrin-bound iron in hemodialysis patients.
Driss F; Vrtovsnik F; Katsahian S; Michel C; Baron G; Kolta A; Sedrati N; Mentré F; Mignon F; Cabantchik I; Grandchamp B
Nephron Clin Pract; 2005; 99(3):c63-7. PubMed ID: 15640610
[TBL] [Abstract][Full Text] [Related]
5. Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation.
Scheiber-Mojdehkar B; Lutzky B; Schaufler R; Sturm B; Goldenberg H
J Am Soc Nephrol; 2004 Jun; 15(6):1648-55. PubMed ID: 15153577
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
[TBL] [Abstract][Full Text] [Related]
7. The effect of serum albumin level on iron-induced oxidative stress in chronic renal failure patients.
Sezer MT; Akin H; Demir M; Erturk J; Aydin ZD; Savik E; Tunc N
J Nephrol; 2007; 20(2):196-203. PubMed ID: 17514624
[TBL] [Abstract][Full Text] [Related]
8. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
9. Non-transferrin-bound iron is associated with enhanced Staphylococcus aureus growth in hemodialysis patients receiving intravenous iron sucrose.
Barton Pai A; Pai MP; Depczynski J; McQuade CR; Mercier RC
Am J Nephrol; 2006; 26(3):304-9. PubMed ID: 16809897
[TBL] [Abstract][Full Text] [Related]
10. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
11. Iron supplementation and oxidative stress in patients with uremia.
Shetty JK; Prakash M
Indian J Physiol Pharmacol; 2007; 51(2):179-82. PubMed ID: 18175664
[TBL] [Abstract][Full Text] [Related]
12. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
[TBL] [Abstract][Full Text] [Related]
13. Minor impairment of oral iron absorption in non-diabetic new dialysis patients.
Tovbin D; Schnaider A; Vorobiov M; Rogachev B; Basok A; Shull P; Novack V; Friger M; Avramov D; Zlotnik M
J Nephrol; 2005; 18(2):174-80. PubMed ID: 15931645
[TBL] [Abstract][Full Text] [Related]
14. Ascorbyl free radical reflects catalytically active iron after intravenous iron saccharate injection.
Stefánsson BV; Haraldsson B; Nilsson U
Free Radic Biol Med; 2008 Nov; 45(9):1302-7. PubMed ID: 18775775
[TBL] [Abstract][Full Text] [Related]
15. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
[TBL] [Abstract][Full Text] [Related]
16. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.
Anraku M; Kitamura K; Shintomo R; Takeuchi K; Ikeda H; Nagano J; Ko T; Mera K; Tomita K; Otagiri M
Clin Biochem; 2008 Oct; 41(14-15):1168-74. PubMed ID: 18692036
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant enzymes show adaptation to oxidative stress in athletes and increased stress in hemodialysis patients.
Knap B; Prezelj M; Buturović-Ponikvar J; Ponikvar R; Bren AF
Ther Apher Dial; 2009 Aug; 13(4):300-5. PubMed ID: 19695063
[TBL] [Abstract][Full Text] [Related]
18. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis.
Lucchi L; Iannone A; Bergamini S; Stipo L; Perrone S; Uggeri S; Gatti V; Ferrari F; Tomasi A; Albertazzi A
Artif Organs; 2005 Oct; 29(10):832-7. PubMed ID: 16185346
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and ferritin levels in haemodialysis patients.
Senol E; Ersoy A; Erdinc S; Sarandol E; Yurtkuran M
Nephrol Dial Transplant; 2008 Feb; 23(2):665-72. PubMed ID: 18039638
[TBL] [Abstract][Full Text] [Related]
20. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin.
Gosriwatana I; Loreal O; Lu S; Brissot P; Porter J; Hider RC
Anal Biochem; 1999 Sep; 273(2):212-20. PubMed ID: 10469492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
